Depression and Anxiety in the Aetiology and Prognosis of Specific Cardiovascular Disease Syndromes: a CALIBER Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
People report feeling sad and low (depression) or worried (anxiety) appear more likely to subsequently suffer a heart attack, or angina. However it is not known whether depression or anxiety actually causes heart disease. If these mental health problems and heart disease were cause and effect this has important implications for world health. Previous research on this topic has had several limitations. First, most studies have studied heart disease as if it were one thing. There is a need for studies which distinguish different types of heart disease (e.g. different types of heart attack, angina) which may be linked to mental health problems in different ways. Second, it is not clear whether symptoms of heart disease come before the depression or anxiety or the other way round? Much of the available research cannot look at this in detail because they rely on data from occasional snapshots of study populations rather than a continuous record. The investigators propose to use the linkage of the national registry of coronary events to general practice records in the GPRD, which will allow us to address these limitations. The investigators research will help us understand better whether mental health problems cause the onset of different types of coronary disease.
| Condition |
|---|
|
Depression Anxiety Coronary Disease Cardiovascular Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Depression and Anxiety in the Aetiology and Prognosis of Specific Cardiovascular Disease Syndromes: a CALIBER Study Using Linked GPRD-MINAP-HES Data |
- Chronic stable angina [ Time Frame: 1 year from date of first presentation ] [ Designated as safety issue: No ]
- Coronary artery bypass graft (CABG) [ Time Frame: 1 year from date of first presentation ] [ Designated as safety issue: No ]
- Acute, non-fatal ST Elevation myocardial infarction, non-ST elevation myocardial infarction, and unstable angina [ Time Frame: 1 year from date of first presentation ] [ Designated as safety issue: No ]
- Death (including sudden death) [ Time Frame: 1 year from date of first presentation ] [ Designated as safety issue: No ]
- Stroke [ Time Frame: 1 year from first presentation ] [ Designated as safety issue: No ]
| Enrollment: | 0 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Depression, anxiety |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
The study population will include all adults (18+) in GPRD registered in up-to-standard practices with at least 1 year of up to standard follow up. Analyses will focus on the ~200 practices which have consented to linkage with HES and MINAP. Essentially we will define an aetiological cohort - whole population - free of any coronary syndrome at start of follow up. Patients within this cohort are followed for the aetiologic endpoint of a first specific coronary syndrome (see below). This aetiologic endpoint is the prognostic start-point; such patients will then be followed for subsequent specific coronary syndromes and death. We will focus analyses on patients with at least a year follow up data before and their endpoint. As in a conventional cohort study we will define according to exposure history.
Inclusion Criteria:
- Aged >18 years
- Patient in a GPRD registered practice that has consented to the linkage process
- Patients are free of any coronary syndrome at the start of follow-up
Exclusion Criteria:
- Less than 1 year of follow-up before their end-point
Contacts and Locations| United Kingdom | |
| Clinical Epidemiology Group, University College London | |
| London, United Kingdom, WC1E 6BT | |
| Principal Investigator: | Harry Hemingway, FRCP | University College, London |
| Study Director: | Harry Hemingway, FRCP | University College, London |
More Information
Additional Information:
No publications provided
| Responsible Party: | Professor Harry Hemingway, University College London |
| ClinicalTrials.gov Identifier: | NCT01240798 History of Changes |
| Other Study ID Numbers: | CALIBER 09-10, Wellcome Trust 086091/Z/08/Z |
| Study First Received: | November 11, 2010 |
| Last Updated: | November 22, 2010 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by University College, London:
|
Depression Anxiety Coronary disease |
Additional relevant MeSH terms:
|
Anxiety Disorders Cardiovascular Diseases Coronary Disease Coronary Artery Disease Depression Depressive Disorder Mental Disorders |
Myocardial Ischemia Heart Diseases Vascular Diseases Arteriosclerosis Arterial Occlusive Diseases Behavioral Symptoms Mood Disorders |
ClinicalTrials.gov processed this record on June 18, 2013